Ordinance
on Clinical Trials
with the exception of
Clinical Trials of Medical Devices1
(Clinical Trials Ordinance, ClinO)

of 20 September 2013 (Status as of 26 May 2022)

1 Amended by Annex 2 No 2 of the O of 1 July 2020 on Clinical Trials with Medical Devices, in force since 26 May 2021 (AS 2020 3033).


Open article in different language:  DE  |  FR  |  IT
Art. 53 Review areas

For clin­ic­al tri­als of trans­plant­a­tion, the FOPH shall re­view:

a.
the com­plete­ness of the ap­plic­a­tion;
b.
the ori­gin of the or­gans, tis­sues or cells used in the clin­ic­al tri­al;
c.
com­pli­ance with the re­quire­ments of the trans­plant­a­tion le­gis­la­tion, par­tic­u­larly with re­gard to the du­ties of care in the hand­ling of or­gans, tis­sues and cells, and the al­loc­a­tion of or­gans;
d.
the avail­ab­il­ity of the au­thor­isa­tions re­quired in ac­cord­ance with the Trans­plant­a­tion Act;
e.
oth­er areas, where this is ne­ces­sary to as­sess the safety and qual­ity of the or­gans, tis­sues or cells used.

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden